Jack Tasse
Director of Finance/CFO bij DELIVRA HEALTH BRANDS INC.
Vermogen: 31 200 $ op 31-03-2024
Profiel
Jack Tasse currently works at Standard Mercantile Acquisition Corp., as Chief Financial Officer from 2021 and Delivra Health Brands, Inc., as Chief Financial Officer & Secretary from 2020.
Mr. Tasse also formerly worked at Therapure Biopharma, Inc., as Finance Director from 2012 to 2016 and Molecular Science Corp., as Chief Financial Officer from 2018 to 2020.
Mr. Tasse received his graduate degree from Brock University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-12-2023 | 1 300 000 ( 0.42% ) | 31 200 $ | 31-03-2024 |
Actieve functies van Jack Tasse
| Bedrijven | Functie | Begin |
|---|---|---|
| DELIVRA HEALTH BRANDS INC. | Director of Finance/CFO | 01-12-2020 |
| TREZ CAPSNRMTG INV A | Director of Finance/CFO | 01-01-2021 |
Eerdere bekende functies van Jack Tasse
| Bedrijven | Functie | Einde |
|---|---|---|
Molecular Science Corp.
 Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Director of Finance/CFO | 01-03-2020 |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Director of Finance/CFO | 01-01-2016 |
Opleiding van Jack Tasse
| Brock University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TREZ CAPSNRMTG INV A | Finance |
| DELIVRA HEALTH BRANDS INC. | Process Industries |
| Bedrijven in privébezit | 2 |
|---|---|
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Molecular Science Corp.
Molecular Science Corp. Miscellaneous Commercial ServicesCommercial Services Molecular Science Corp. provides laboratory services. The firm offers GC-MS and LC-MS analysis, cannabis laboratory testing services, mobile testing services, and scientific resources. The company was founded by Scott R. Walters and Sameet Kanade on January 24, 2017 and is headquartered in Toronto, Canada. | Commercial Services |
